Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Vetnostrum Animal Health Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	119.57	136.62	91.6	106.52
Depreciation & Amortization	74.7	76.15	76.74	78.22
Loss (Gain) From Sale of Assets	-	1.89	-0.04	0.05
Stock-Based Compensation	8.3	-	-	5.3
Provision & Write-off of Bad Debts	-	-	-0.1	0.01
Other Operating Activities	-12.05	12.78	-4.18	-1.12
Change in Accounts Receivable	-25.84	-28.05	10.74	10.41
Change in Inventory	-20.16	-56.19	13.72	-34.12
Change in Accounts Payable	15.22	12.6	24.44	-26.28
Change in Unearned Revenue	-	-	-	-4.36
Change in Other Net Operating Assets	-10.56	24.59	22.57	-7.06
Operating Cash Flow	152.58	180.39	235.49	127.56
Operating Cash Flow Growth	-0.63%	-23.40%	84.61%	-
Capital Expenditures	-23.31	-30.2	-15.49	-22.05
Sale of Property, Plant & Equipment	-	-	0.04	0.36
Investment in Securities	-199.94	-10	-	-
Other Investing Activities	0.32	-0.44	-0.33	3.87
Investing Cash Flow	-222.93	-40.64	-15.78	-17.83
Short-Term Debt Issued	-	350	580	970
Total Debt Issued	60	350	580	970
Short-Term Debt Repaid	-	-420	-700	-890
Long-Term Debt Repaid	-	-9.09	-8.56	-148.42
Total Debt Repaid	-101.25	-429.09	-708.56	-1,038
Net Debt Issued (Repaid)	-41.25	-79.09	-128.56	-68.42
Issuance of Common Stock	207.46	0.83	1.27	53
Common Dividends Paid	-122.73	-68.94	-80.12	-82.5
Financing Cash Flow	43.49	-147.2	-207.4	-97.92
Net Cash Flow	-26.86	-7.46	12.31	11.81
Free Cash Flow	129.27	150.19	220	105.51
Free Cash Flow Growth	1.24%	-31.74%	108.51%	-
Free Cash Flow Margin	9.44%	11.61%	18.22%	8.90%
Free Cash Flow Per Share	1.86	2.27	3.31	1.66
Cash Interest Paid	0.59	1.15	2.17	2.94
Cash Income Tax Paid	38.44	18.96	25.15	26.43
Levered Free Cash Flow	-	118.21	204.08	-
Unlevered Free Cash Flow	-	118.9	205.32	-
Change in Working Capital	-41.34	-47.05	71.47	-61.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.